The impaired inflammatory response in COVID-19 patients may be due to a singular low expression of type I and III IFNs, resulting in reduction of antiviral defense, associated with elevated NF-kB-induced chemokines, leading to leukocytes recruitment and high expression of proinflammatory IL-6 [48]. The gene discussed is IL6; the disease is COVID-19.